Cancer: progress and gaps

Australia is on track to eliminate cervical cancer, proof of what funding and screening can do. But ovarian cancer still has no early detection test, and women face a higher risk of severe side effects from cancer treatment.

Cancer shows both sides of the women’s health story. Where there has been steady funding, a vaccine and a screening program, the results are clear. Where there has not, the gaps remain.

Progress: cervical cancer. A virus called HPV (human papillomavirus) causes almost all cases of cervical cancer [1]. Australia vaccinates against HPV and screens for it. Women and people with a cervix aged 25 to 74 are invited to have a Cervical Screening Test every five years, and can choose to collect their own sample [6]. Australia now aims to eliminate cervical cancer as a public health problem by 2035. That means fewer than 4 new cases a year for every 100,000 women [1].

Gap: ovarian cancer. There is no screening test for ovarian cancer. Cancer Australia says no test can yet find it accurately at an early stage, and a Cervical Screening Test does not detect it [3]. In 2017–2021, people diagnosed with ovarian cancer had a 49% chance of surviving five years, compared with the general population. That is up from 36% in 1987–1991 [4].

Gap: treatment side effects. A study of 23,296 patients in 202 US cancer treatment trials found that women were 34% more likely than men to have severe side effects. For immunotherapy, a newer type of cancer treatment, the risk was 49% higher [5].

2035

The year by which Australia aims to eliminate cervical cancer as a public health problem. Elimination means fewer than 4 new cases a year for every 100,000 women.
AustraliaSource 1

6.3

New cases of cervical cancer for every 100,000 women in 2021, down from 6.6 in 2020. As reported in a government media release on the 2025 progress report.
AustraliaSource 2

0

Cervical cancer cases diagnosed in women under 25 in 2021. It was the first year with none since records began in 1982. From the same media release.
AustraliaSource 2

49%

Chance of surviving five years after an ovarian cancer diagnosis, compared with the general population (2017–2021). It was 36% in 1987–1991.
AustraliaSource 4

34%

Higher risk of severe side effects for women than for men (odds ratio 1.34) across 202 US cancer treatment trials run between 1980 and 2019. Cancers that affect only one sex were left out.
GlobalSource 5

Why it matters in Australia

The cervical cancer figures show what sustained effort can do. In 2021 the rate of new cases fell to 6.3 for every 100,000 women, from 6.6 the year before. No cases were diagnosed in women under 25, for the first time since records began in 1982. The chance of surviving five years rose to 76.8% in 2017–2021, from 73.9% in 2012–2016 [2]. These figures come from a government media release about the 2025 progress report, not from the report itself.

The work is not finished. The same release says HPV vaccination and cervical screening rates have both fallen slightly [2]. Australia’s targets for 2030 are for 90% of eligible people, girls and boys, to be vaccinated, 70% of eligible people to be screened every five years, and 95% to get treatment when they need it [1].

For ovarian cancer there is no such program to build on. Cancer Australia estimates that 1,929 new cases will be diagnosed in 2025 [4]. The charts below show how many women die from ovarian and cervical cancer each year, and how death rates have changed since 1990.

What needs to change

If you are worried about symptoms or are due for screening, talk to your GP. Cancer Australia has information on ovarian cancer, and the National Cervical Screening Program explains how screening works.

Global context

The side effects study used US trials run by one research network between 1980 and 2019. It left out cancers that affect only one sex, so it compares women and men having treatment for the same kinds of cancer. It is tagged Global because it is not Australian data [5].

In numbers

From the In numbers page. Each chart lists its own source.

Australia1990–2023

Cervical cancer death rates for Australian women fell by 47% between 1990 and 2023.

Age-standardised death rates per 100,000, Australian women, 1990, 2010, 2023Heart disease: 132.2 → 47.9 → 26.1 (down 80%); Stroke: 61.3 → 29.4 → 17.8 (down 71%); Breast cancer: 26.5 → 18.4 → 14.4 (down 46%); Ovarian cancer: 7.3 → 5.8 → 4.6 (down 36%); Cervical cancer: 3.8 → 2.3 → 2.0 (down 47%).Deaths per 100,000 women (age-standardised)070140199020102023Heart disease −80%Stroke −71%Breast cancer −46%Ovarian cancer −36%Cervical cancer −47%
Fall in age-standardised death rates for Australian women, 1990 to 2023: heart disease 80%, stroke 71%, breast cancer 46%, ovarian cancer 36%, cervical cancer 47%.
Show the data
Age-standardised death rates per 100,000, Australian women (GBD 2023)
Cause199020102023Fall, 1990–2023
Heart disease132.247.926.180.3%
Stroke61.329.417.870.9%
Breast cancer26.518.414.445.8%
Ovarian cancer7.35.84.636.4%
Cervical cancer3.82.32.046.7%

Age-standardised rates; falls are similar for men. Investment in research, prevention and treatment works.

Source: Global Burden of Disease Collaborative Network, GBD 2023 Results (IHME, 2024). Data: gbd_au_women_death_rates_1990_2023.csv

Australia2025

Ovarian cancer killed 1,043 Australian women in 2025. Cervical cancer killed 250.

Australia2025

Deaths: ovarian and cervical cancer

Cervical cancer has a national screening program. Ovarian cancer has no screening test.

Deaths of Australian women from ovarian and cervical cancer, 2025Ovarian cancer: 1,043 deaths. Cervical cancer: 250 deaths.Ovarian cancerDeaths 1,043Cervical cancerDeaths 250
Deaths of Australian women registered in 2025: ovarian cancer 1,043, cervical cancer 250.
Show the data
Australian women, deaths registered in 2025
Cause (ABS name)Deaths
Malignant neoplasm of ovary (C56)1,043
Malignant neoplasm of cervix uteri (C53)250

Source: ABS, Causes of Death, Australia, 2025. Data: abs_cod_2025_by_cause_sex.csv

Australia2024

Screening: Australia and other countries

Share of women screened, Australia vs the median of other countries reporting (OECD programme data)Cervical screening: Australia 77.9%, other countries' median 60.6%; Breast screening: Australia 52.0%, other countries' median 53.8%.Cervical screening (ages 20–69)Australia 77.9%Other countries, median 60.6%Breast screening (ages 50–69)Australia 52.0%Other countries, median 53.8%
Cervical screening (ages 20–69), 2024: Australia 77.9%, median of 36 other countries 60.6%. Breast screening (ages 50–69), 2024: Australia 52.0%, median of 38 other countries 53.8%.
Show the data
Women screened, programme data (%)
ScreeningYearAustraliaMedian, other countriesCountries reporting
Cervical screening (ages 20–69)202477.9%60.6%36
Breast screening (ages 50–69)202452.0%53.8%38

OECD status for Australia: cervical screening "Definition differs".

OECD measures breast screening at ages 50–69; BreastScreen Australia invites women aged 50–74. OECD flags Australia's cervical screening figure: "Definition differs".

Source: OECD Health Statistics, cancer screening. Data: oecd_cancer_screening.csv

Sources

  1. National Strategy for the Elimination of Cervical Cancer in Australia. Australian Government Department of Health and Aged Care, 2023.
  2. Australia on track to eliminate cervical cancer by 2035 (media release on the 2025 Cervical Cancer Elimination Progress Report). Australian Government, 2025.
  3. Ovarian cancer screening. Cancer Australia.
  4. Ovarian cancer statistics in Australia. Cancer Australia.
  5. Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials (Unger JM et al.). Journal of Clinical Oncology, 40(13), 2022.
  6. National Cervical Screening Program. Australian Government Department of Health, Disability and Ageing.

Last reviewed: [NOT YET REVIEWED]